rs10106920 CSMD1 EBV VCA p18 antibody levels
Upload your raw genetic data once, we'll show you which variants you carry and what the research says.
Key takeaways
- rs10106920 in CSMD1 is linked to higher EBV VCA p18 antibody levels
- the effect size is 66.66 with a very low p-value
- sample size was about 12 thousand individuals
Key takeaways rs10106920 in CSMD1 is linked to higher EBV VCA p18 antibody levels the effect size is 66.66 with a very low p-value sample size was about 12 thousand individuals
What the research says This variant is associated with Epstein-Barr virus VCA p18 antibody levels, reported effect size 66.66, p=1e-5, in about 12 thousand individuals [PMID 38630618].
Reported associations Epstein-Barr virus VCA p18 antibody levels: the variant is associated with higher levels, reported effect size 66.66, p=1e-5, in about 12 thousand individuals [PMID 38630618].
Evidence quality The study is a genome-wide association study of about 12 thousand individuals, reporting a strong association with EBV VCA p18 antibody levels (p=1e-5). The effect size is reported as 66.66 [PMID 38630618].
Lifestyle considerations No lifestyle considerations on file for this variant.
Frequently asked questions
What does rs10106920 do?
It is linked to higher EBV VCA p18 antibody levels in people who carry the variant.
Is this a disease gene?
The study shows an association with EBV immune response, not a direct disease cause.
How strong is the link?
The effect size is 66.66 and the p-value is 1e-5 indicating a very strong statistical signal.